You are currently on the new version of our website. Access the old version .
MDPIMDPI

3 Results Found

  • Article
  • Open Access
1 Citations
2,052 Views
11 Pages
Download PDF

The Effect of Cooling Fluid Composition on Ablation Size in Hepatic Laser Ablation: A Comparative Study in an Ex Vivo Bovine Setting

  • Fiona Mankertz,
  • Nadine Bayerl,
  • Ole Gemeinhardt,
  • Norbert Hosten and
  • Marie-Luise Kromrey
Tomography2023, 9(5), 1638-1648;https://doi.org/10.3390/tomography9050131

1 September 2023

Purpose: Hyperthermic ablation is a minimally invasive mode of tumour therapy which serves as a viable alternative to surgical intervention. However, one of the major drawbacks, besides the heat sink effect and the risk of damaging adjacent organs, i...

Full Article
  • Article
  • Open Access
5 Citations
2,792 Views
14 Pages
Download PDF

Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score® Test?

  • Francesca Galati,
  • Valentina Magri,
  • Giuliana Moffa,
  • Veronica Rizzo,
  • Andrea Botticelli,
  • Enrico Cortesi and
  • Federica Pediconi
Diagnostics2022, 12(11), 2730;https://doi.org/10.3390/diagnostics12112730

8 November 2022

The aim of this study was to combine breast MRI-derived biomarkers with clinical-pathological parameters to identify patients who truly need an Oncotype DX Breast Recurrence Score® (ODXRS) genomic assay, currently used to predict the benefit of a...

Full Article
  • Article
  • Open Access
1,211 Views
15 Pages
Download PDF

The Effectiveness of SBRT for Solitary or Synchronous Multiple Pulmonary Nodules Suspicious of Early-Stage Lung Cancer Without Pathological Confirmation

  • Emese Csiki,
  • Dóra Bölcskei,
  • Márton Barabás,
  • Kristóf Gál,
  • Johanna Mikáczó,
  • Szidónia Miklós,
  • Krisztina Trási,
  • Dóra Solymosi,
  • Judit Papp and
  • Árpád Kovács
Biomedicines2025, 13(10), 2534;https://doi.org/10.3390/biomedicines13102534

17 October 2025

Background: Stereotactic body radiotherapy (SBRT) is an established curative modality for patients with early-stage non-small cell lung cancer (NSCLC) who are not candidates for surgery. In circumstances where neither surgical resection nor tissue sa...

Full Article